Literature DB >> 8971396

Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma.

J Gabarre1, V Leblond, L Sutton, N Azar, M Jouan, C Boccaccio, H Gonzalez, F Charlotte, M Gentilini, J L Binet.   

Abstract

There are few reports of salvage chemotherapy for HIV-related non-Hodgkin's lymphoma (NHL). We report a relapsed HIV-related high-grade NHL which was treated successfully with ESHAP chemotherapy followed by high-dose chemotherapy and autologous bone marrow transplantation (ABMT). ABMT may later have triggered opportunistic infections in this patient.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8971396

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  8 in total

1.  Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation.

Authors:  Ann E Woolfrey; Uma Malhotra; Robert D Harrington; John McNevin; Thomas J Manley; Stanley R Riddell; Robert W Coombs; Frederick R Appelbaum; Larry Corey; Rainer Storb
Journal:  Blood       Date:  2008-08-12       Impact factor: 22.113

2.  Autologous stem cell transplantation for lymphoma in HIV+ patients: higher rate of infections compared with non-HIV lymphoma.

Authors:  Mariana Bastos-Oreiro; Pascual Balsalobre; Pilar Miralles; Juan Berenguer; Nieves Dorado; Rebeca Bailen; Gillen Obreoscoa; Javier Anguita; David Serrano; José Luis Díez-Martín; Mi Kwon
Journal:  Bone Marrow Transplant       Date:  2020-03-04       Impact factor: 5.483

3.  HIV status does not affect the outcome of autologous stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL).

Authors:  Amrita Krishnan; Joycelynne M Palmer; John A Zaia; Ni-Chun Tsai; Joseph Alvarnas; Stephen J Forman
Journal:  Biol Blood Marrow Transplant       Date:  2010-03-28       Impact factor: 5.742

4.  Autologous peripheral blood stem cell transplantation for relapsed/refractory HIV-associated lymphoma: a phase II clinical study.

Authors:  Shotaro Hagiwara; Hirokazu Nagai; Tomoko Uehira; Akiko M Saito; Seiji Okada
Journal:  Int J Hematol       Date:  2019-12-13       Impact factor: 2.490

Review 5.  Hematopoietic stem cell transplantation for AIDS-related malignancies.

Authors:  Amrita Krishnan; Stephen J Forman
Journal:  Curr Opin Oncol       Date:  2010-09       Impact factor: 3.645

6.  Safety and Efficacy of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Adults Undergoing Autologous or Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies.

Authors:  Christine Johnston; Robert Harrington; Rupali Jain; Joshua Schiffer; Hans-Peter Kiem; Ann Woolfrey
Journal:  Biol Blood Marrow Transplant       Date:  2015-08-08       Impact factor: 5.742

Review 7.  Stem cell transplantation in HIV-infected patients.

Authors:  Amrita Krishnan
Journal:  Curr Opin HIV AIDS       Date:  2009-01       Impact factor: 4.283

8.  Successful unrelated bone marrow transplantation for a human immunodeficiency virus type-1-seropositive acute myelogenous leukemia patient following HAART.

Authors:  Yoko Oka; Haruko Tashiro; Mitsuho Mizutani-Noguchi; Ichiro Koga; Toshihiko Sugao; Ryosuke Shirasaki; Toshiyuki Miura; Nobu Akiyama; Kazuo Kawasugi; Shin Fujimori; Naoki Shirafuji
Journal:  Int J Hematol       Date:  2009-12-25       Impact factor: 2.490
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.